Literature DB >> 19752527

Age-related changes of anti-elastin antibodies in senescence-accelerated mice.

Milena Atanasova1, Emiliana Konova, Miglena Georgieva, Anelja Dimitrova, Marion Coquand-Gandit, Gilles Faury, Stephan Baydanoff.   

Abstract

BACKGROUND: Antibodies recognizing the elastin precursor tropoelastin (ATEAb) or degradation products alpha-elastin (AEAb) are found in the serum of healthy human subjects, as a part of a homeostatic mechanism which assembles new or clears altered elastin structures. Serum ATEAb (reflecting elastin synthesis) and AEAb (reflecting elastin destruction) appear to correlate with the production and breakdown of the elastic tissue, respectively.
OBJECTIVE: The aim of this study was to investigate plasma levels of AEAb and ATEAb in senescence-accelerated prone (SAMP8) and senescence-accelerated resistant (SAMR1) mice, compared with imprinting control region (ICR) mice in order to evaluate their age-related changes.
METHODS: The levels of AEAb and ATEAb were measured by home-made ELISA in plasma of SAMP8, SAMR1, and ICR mice, grouped according to their age (3 and 9 months) and sex. The specificity of AEAb and ATEAb activity in mouse plasma, and elastin-derived peptides (EDP) in sera of ICR mice at 3 and 9 months of age were tested by competitive ELISA.
RESULTS: The specificity of AEAb and ATEAb in mouse plasma was confirmed by the competitive investigations. The levels of AEAb in the plasma of SAMR1 and SAMP8 were increased compared to the levels measured in ICR on the matched ages (p < 0.001). Age-related increase of the levels of AEAb and ATEAb was established in the 3 strains (p < 0.001). Significantly higher levels of AEAb were established in female 9-month-old mice compared to males in all strains. The ATEAb:AEAb ratio was significantly lower in the SAM compared to the ICR strain. Positive correlation was established between the levels of serum AEAb and EDP in mouse sera of ICR mice.
CONCLUSION: Variations with age in the plasma levels of AEAb and ATEAb were established in SAM compared with ICR, and in SAMP8 compared with SAMR1. Our findings suggest that increased anti-elastin IgG autoantibodies could be used as a marker of aging in SAM and possibly contribute to the processes of aging. The absence of a difference between SAMP8 and SAMR1 regarding the ATEAb:AEAb ratio raises the question if SAMR1 are an appropriate control of SAMP8 in terms of the senescence of the elastic tissues. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752527     DOI: 10.1159/000238304

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  4 in total

Review 1.  Age-associated proinflammatory elastic fiber remodeling in large arteries.

Authors:  Soo Hyuk Kim; Robert E Monticone; Kimberly R McGraw; Mingyi Wang
Journal:  Mech Ageing Dev       Date:  2021-04-08       Impact factor: 5.498

2.  Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial.

Authors:  Behrouz Kassai; Philippe Bouyé; Brigitte Gilbert-Dussardier; François Godart; Jean-Benoit Thambo; Massimiliano Rossi; Pierre Cochat; Pierre Chirossel; Stephane Luong; André Serusclat; Isabelle Canterino; Catherine Mercier; Muriel Rabilloud; Christine Pivot; Fabrice Pirot; Tiphanie Ginhoux; Stéphanie Coopman; Guillaume Grenet; François Gueyffier; Sylvie Di-Fillippo; Aurélia Bertholet-Thomas
Journal:  BMC Pediatr       Date:  2019-05-28       Impact factor: 2.125

3.  Circulating Anti-Elastin Antibody Levels and Arterial Disease Characteristics: Associations with Arterial Stiffness and Atherosclerosis.

Authors:  Seung-Hyun Lee; Kihyuk Shin; Sungha Park; Seok-Min Kang; Donghoon Choi; Seung-Hyo Lee; Sang-Hak Lee
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

4.  Proteomic data show an increase in autoantibodies and alpha-fetoprotein and a decrease in apolipoprotein A-II with time in sera from senescence-accelerated mice.

Authors:  S J Guo; C H Qi; W X Zhou; Y X Zhang; X M Zhang; J Wang; H X Wang
Journal:  Braz J Med Biol Res       Date:  2013-04-12       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.